Clinical Trial Manufacturing and Distribution Services

  • Nottingham Trent University (NTU)

F14: Notice for changes or additional information

Notice identifier: 2024/S 000-024409

Procurement identifier (OCID): ocds-h6vhtk-0458a3

Published 3 August 2024, 8:34am



Section one: Contracting authority/entity

one.1) Name and addresses

Nottingham Trent University (NTU)

50 Shakespeare Street

Nottingham

NG1 4FQ

Contact

Mark Lucas

Email

mark.lucas@ntu.ac.uk

Telephone

+44 1158488747

Country

United Kingdom

Region code

UKF14 - Nottingham

National registration number

GB 277399933

Internet address(es)

Main address

https://www.ntu.ac.uk/

Buyer's address

https://uk.eu-supply.com/ctm/Company/CompanyInformation/Index/128806


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Clinical Trial Manufacturing and Distribution Services

Reference number

NTU/24/2615T/ML

two.1.2) Main CPV code

  • 33600000 - Pharmaceutical products

two.1.3) Type of contract

Supplies

two.1.4) Short description

Nottingham Trent University requires Clinical Trial Manufacturing and Distribution Services for manufacturing and distribution of fluoxetine (20mg) and a matching placebo.


Section six. Complementary information

six.6) Original notice reference

Notice number: 2024/S 000-024231


Section seven. Changes

seven.1) Information to be changed or added

seven.1.2) Text to be corrected in the original notice

Section number

1.5

Place of text to be modified

Section IV: Procedure

Read
Text

Nottingham Trent University reserves the right to award the contract on the basis of the initial tenders without conducting negotiations.

seven.2) Other additional information

Nottingham Trent University reserves the right to award the contract on the basis of the initial tenders without conducting negotiations.